...
search icon
ogn-img

Organon & Co Share Price

OGN
NYQ
$7.06
-$0.63
(-8.19%)
1D
Industry: Pharmaceuticals Sector: Health Care

Organon & Co Analyst Forecast

Organon & Co Share Price Chart

Organon & Co Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.00B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
4.0262
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.63M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
7.59%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.55
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.16 L
$16.8 H
$7.06

About Organon & Co, Common Stock

Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon, which are daily pills used to prevent pregnancy; Follistim AQ, which is used to promote the development of multiple ovarian follicles in medically assisted reproduction procedures; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding or hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products used to control and prevent asthma-induced symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company sells its products to drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Organon & Co Stock Returns

Time FrameOGNSectorS&P500
1-Week Return-12.84%0.91%2.13%
1-Month Return-13.05%-0.72%-0.47%
3-Month Return-8.43%2.24%1.29%
6-Month Return-21.99%19.1%7.71%
1-Year Return-51.97%7.15%14.7%
3-Year Return-76.05%16.96%67.75%
5-Year Return-78.77%33.23%76.25%

Organon & Co Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.53B6.30B6.17B6.26B6.40B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":96.51,"profit":true},{"date":"2022-12-31","value":94.52,"profit":true},{"date":"2023-12-31","value":95.88,"profit":true},{"date":"2024-12-31","value":98.03,"profit":true}]
Cost of Revenue2.12B2.38B2.29B2.52B2.69B[{"date":"2020-12-31","value":78.83,"profit":true},{"date":"2021-12-31","value":88.62,"profit":true},{"date":"2022-12-31","value":85.34,"profit":true},{"date":"2023-12-31","value":93.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit4.41B3.92B3.88B3.75B3.71B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":88.87,"profit":true},{"date":"2022-12-31","value":87.92,"profit":true},{"date":"2023-12-31","value":84.93,"profit":true},{"date":"2024-12-31","value":84.18,"profit":true}]
Gross Margin67.56%62.21%62.84%59.84%58.02%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":92.09,"profit":true},{"date":"2022-12-31","value":93.02,"profit":true},{"date":"2023-12-31","value":88.58,"profit":true},{"date":"2024-12-31","value":85.88,"profit":true}]
Operating Expenses1.57B2.01B2.17B2.42B2.23B[{"date":"2020-12-31","value":64.68,"profit":true},{"date":"2021-12-31","value":82.9,"profit":true},{"date":"2022-12-31","value":89.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.07,"profit":true}]
Operating Income2.85B1.92B1.71B1.33B1.49B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":67.26,"profit":true},{"date":"2022-12-31","value":59.89,"profit":true},{"date":"2023-12-31","value":46.61,"profit":true},{"date":"2024-12-31","value":52.2,"profit":true}]
Total Non-Operating Income/Expense(95.00M)(644.00M)(1.00B)(1.17B)(1.20B)[{"date":"2020-12-31","value":-9500000000,"profit":false},{"date":"2021-12-31","value":-64400000000,"profit":false},{"date":"2022-12-31","value":-100500000000,"profit":false},{"date":"2023-12-31","value":-117100000000,"profit":false},{"date":"2024-12-31","value":-119900000000,"profit":false}]
Pre-Tax Income2.75B1.53B1.12B673.00M807.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.56,"profit":true},{"date":"2022-12-31","value":40.77,"profit":true},{"date":"2023-12-31","value":24.45,"profit":true},{"date":"2024-12-31","value":29.32,"profit":true}]
Income Taxes496.00M178.00M205.00M(350.00M)(57.00M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.89,"profit":true},{"date":"2022-12-31","value":41.33,"profit":true},{"date":"2023-12-31","value":-70.56,"profit":false},{"date":"2024-12-31","value":-11.49,"profit":false}]
Income After Taxes2.26B1.35B917.00M1.02B864.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":59.88,"profit":true},{"date":"2022-12-31","value":40.65,"profit":true},{"date":"2023-12-31","value":45.35,"profit":true},{"date":"2024-12-31","value":38.3,"profit":true}]
Income From Continuous Operations2.16B1.35B917.00M585.00M864.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.55,"profit":true},{"date":"2022-12-31","value":42.45,"profit":true},{"date":"2023-12-31","value":27.08,"profit":true},{"date":"2024-12-31","value":40,"profit":true}]
Income From Discontinued Operations(96.00M)----[{"date":"2020-12-31","value":-9600000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income2.16B1.35B917.00M1.02B864.00M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.55,"profit":true},{"date":"2022-12-31","value":42.45,"profit":true},{"date":"2023-12-31","value":47.36,"profit":true},{"date":"2024-12-31","value":40,"profit":true}]
EPS (Diluted)-6.345.034.144.11[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.34,"profit":true},{"date":"2023-12-31","value":65.3,"profit":true},{"date":"2024-12-31","value":64.83,"profit":true}]

Organon & Co Ratios

Organon & Co Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

OGN
Cash Ratio 0.25
Current Ratio 1.75
Quick Ratio 1.20

Organon & Co Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OGN
ROA (LTM) 6.40%
ROE (LTM) 71.62%

Organon & Co Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OGN
Debt Ratio Lower is generally better. Negative is bad. 0.93
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.07

Organon & Co Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OGN
Trailing PE 4.03
Forward PE 5.03
P/S (TTM) 0.32
P/B 2.21
Price/FCF 13
EV/R 1.61
EV/Ebitda 6.51

FAQs

What is Organon & Co share price today?

Organon & Co (OGN) share price today is $7.06

Can Indians buy Organon & Co shares?

Yes, Indians can buy shares of Organon & Co (OGN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Organon & Co be purchased?

Yes, you can purchase fractional shares of Organon & Co (OGN) via the Vested app. You can start investing in Organon & Co (OGN) with a minimum investment of $1.

How to invest in Organon & Co shares from India?

You can invest in shares of Organon & Co (OGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in OGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Organon & Co shares
What is Organon & Co 52-week high and low stock price?

The 52-week high price of Organon & Co (OGN) is $16.8. The 52-week low price of Organon & Co (OGN) is $6.16.

What is Organon & Co price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Organon & Co (OGN) is 4.0262

What is Organon & Co price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Organon & Co (OGN) is 2.21

What is Organon & Co dividend yield?

The dividend yield of Organon & Co (OGN) is 7.59%

What is the Market Cap of Organon & Co?

The market capitalization of Organon & Co (OGN) is $2.00B

What is Organon & Co's stock symbol?

The stock symbol (or ticker) of Organon & Co is OGN

How Can Investors Use Organon & Co Share Price Data for Long-Term Investment Decisions?

Consider the share price of Organon & Co as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Organon & Co has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Organon & Co shares for Indian investors?

When investing in Organon & Co shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Organon & Co stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Organon & Co share price with other stocks in the same sector?

Rather than merely checking the share price of Organon & Co and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Organon & Co stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top